Your browser doesn't support javascript.
loading
Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease.
Shrestha, Pradeep; Turan, Ali; Batra, Lalit; Gulen, Ayse Ece; Sun, Zhengda; Tan, Helen; Askenasy, Nadir; Shirwan, Haval; Yolcu, Esma S.
Afiliação
  • Shrestha P; Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY.
  • Turan A; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO.
  • Batra L; Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY.
  • Gulen AE; Department of Child Health, School of Medicine, University of Missouri, Columbia, MO.
  • Sun Z; Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY.
  • Tan H; Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY.
  • Askenasy N; Frankel Laboratory of Experimental Bone Marrow Transplantation, Petach Tikva, Israel.
  • Shirwan H; Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY.
  • Yolcu ES; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO.
Blood Adv ; 7(10): 2181-2195, 2023 05 23.
Article em En | MEDLINE | ID: mdl-36780582

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Limite: Animals / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article